Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study.
Martínez-Baz I, Navascués A, Trobajo-Sanmartín C, Pozo F, Fernández-Huerta M, Olazabal-Arruiz M, Argente-Colas L, Ezpeleta G, Echeverria A, Casado I, Ezpeleta C, Castilla J. Martínez-Baz I, et al. Among authors: fernandez huerta m. Int J Infect Dis. 2024 Dec 16:107364. doi: 10.1016/j.ijid.2024.107364. Online ahead of print. Int J Infect Dis. 2024. PMID: 39694231 Free article.
Necrotizing fasciitis from a spider bite?
Uribarri García A, Aguinaga Pérez A, Fernández Huerta M, Ezpeleta Baquedano C. Uribarri García A, et al. Among authors: fernandez huerta m. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Nov;42(9):529-530. doi: 10.1016/j.eimce.2024.05.002. Epub 2024 May 11. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 38734589 No abstract available.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Rose AMC, Pozo F, Martínez-Baz I, Mazagatos C, Bossuyt N, Cauchi JP, Petrović G, Loghin II, Vaikutyte R, Buda S, Machado A, Duffy R, Oroszi B, Howard J, Echeverria A, Andreu C, Barbezange C, Džiugytė A, Nonković D, Popescu CP, Majauskaite F, Tolksdorf K, Gomez V, Domegan L, Horváth JK, Castilla J, García M, Demuyser T, Borg ML, Tabain I, Lazar M, Kubiliute I, Dürrwald R, Guiomar R, O'Donnell J, Kristóf K, Nicolay N, Bacci S, Kissling E; VEBIS SARI VE network team; Belgium SARI Surveillance Network (BelsariNet). Rose AMC, et al. Influenza Other Respir Viruses. 2024 Feb;18(2):e13255. doi: 10.1111/irv.13255. Influenza Other Respir Viruses. 2024. PMID: 38403302 Free PMC article.
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021-2022.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Egüés N, García Cenoz M, Casado I, Navascués A, Fernández-Huerta M, Echeverría A, Guevara M, Ezpeleta C, Castilla J. Martínez-Baz I, et al. Among authors: fernandez huerta m. Vaccines (Basel). 2024 Jan 7;12(1):58. doi: 10.3390/vaccines12010058. Vaccines (Basel). 2024. PMID: 38250871 Free PMC article.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors). Rose AM, et al. Euro Surveill. 2023 Nov;28(47):2300186. doi: 10.2807/1560-7917.ES.2023.28.47.2300186. Euro Surveill. 2023. PMID: 37997666 Free PMC article.
Multicenter clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing.
Fernández-Huerta M, Salmerón P, Hernández-Hermida Y, Andrés C, Niubó J, Calatayud L, Domínguez MÁ, Pumarola T, Ardanuy C, Antón A, Càmara J. Fernández-Huerta M, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Oct;41(8):462-467. doi: 10.1016/j.eimce.2022.01.007. Epub 2023 Apr 17. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 37076332 Free PMC article.
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Martínez-Baz I, Trobajo-Sanmartín C, Miqueleiz A, Casado I, Navascués A, Burgui C, Ezpeleta C, Castilla J, Guevara M; Working Group for the Study of COVID-19 in Navarra; Members of the Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Euro Surveill. 2023 Feb;28(5):2200337. doi: 10.2807/1560-7917.ES.2023.28.5.2200337. Euro Surveill. 2023. PMID: 36729113 Free PMC article.
50 results